Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Overman

Showing results (81-90 of 265) with videos related to

Pageof 27
Sort By:
ESMO Open|May 3, 2021
Metastatic small bowel adenocarcinoma: role of metastasectomy and systemic chemotherapyD Bhamidipati, A Colina, H Hwang, et al.
Cancer|November 19, 2016
Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 studyPat Gulhati, Kanwal Raghav, Rachna T Shroff, et al.
Clinical Colorectal Cancer|July 30, 2014
Progression-free survival remains poor over sequential lines of systemic therapy in patients with BRAF-mutated colorectal cancerVan Morris, Michael J Overman, Zhi-Qin Jiang, et al.
Cancer|November 12, 2009
Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experienceJamie F Shapiro, Judy L Chase, Robert A Wolff, et al.
Nature Neuroscience|November 9, 2010
An age-related sprouting transcriptome provides molecular control of axonal sprouting after strokeSonglin Li, Justine J Overman, Diana Katsman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H)J Goldstein, B Tran, J Ensor, et al.
BMC Cancer|August 24, 2016
Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinomaMichael J Overman, Harris S Soifer, Aaron Joel Schueneman, et al.
Clinical Colorectal Cancer|July 19, 2020
Bevacizumab Does Not Influence the Efficacy of Partial Splenic Embolization in the Management of Chemotherapy-Induced HypersplenismAlexandre A Jácome, Aki Ohinata, Armeen Mahvash, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapyScott Kopetz, George J Chang, Michael J Overman, et al.
British Journal of Cancer|May 20, 2015
Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinomaA Schueneman, M Goggins, J Ensor, et al.
Pageof 27

Showing results (81-90 of 265) with videos related to

Sort By:
Pageof 27
ESMO Open|May 3, 2021
Metastatic small bowel adenocarcinoma: role of metastasectomy and systemic chemotherapyD Bhamidipati, A Colina, H Hwang, et al.
Cancer|November 19, 2016
Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 studyPat Gulhati, Kanwal Raghav, Rachna T Shroff, et al.
Clinical Colorectal Cancer|July 30, 2014
Progression-free survival remains poor over sequential lines of systemic therapy in patients with BRAF-mutated colorectal cancerVan Morris, Michael J Overman, Zhi-Qin Jiang, et al.
Cancer|November 12, 2009
Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experienceJamie F Shapiro, Judy L Chase, Robert A Wolff, et al.
Nature Neuroscience|November 9, 2010
An age-related sprouting transcriptome provides molecular control of axonal sprouting after strokeSonglin Li, Justine J Overman, Diana Katsman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H)J Goldstein, B Tran, J Ensor, et al.
BMC Cancer|August 24, 2016
Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinomaMichael J Overman, Harris S Soifer, Aaron Joel Schueneman, et al.
Clinical Colorectal Cancer|July 19, 2020
Bevacizumab Does Not Influence the Efficacy of Partial Splenic Embolization in the Management of Chemotherapy-Induced HypersplenismAlexandre A Jácome, Aki Ohinata, Armeen Mahvash, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapyScott Kopetz, George J Chang, Michael J Overman, et al.
British Journal of Cancer|May 20, 2015
Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinomaA Schueneman, M Goggins, J Ensor, et al.
Pageof 27